Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000652239 | SCV000774107 | likely benign | Tumor predisposition syndrome 3 | 2024-06-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406469 | SCV002715814 | likely benign | Hereditary cancer-predisposing syndrome | 2021-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV005034221 | SCV005666446 | uncertain significance | Tumor predisposition syndrome 3; Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 8; Cerebroretinal microangiopathy with calcifications and cysts 3 | 2024-04-10 | criteria provided, single submitter | clinical testing |